Moreover, KMO inhibition peripherally increased kynurenic acid levels, reduced glutamate, and showed potential in preventing neurodegeneration in Alzheimer’s and Huntington’s disease mouse models (37). This evidence concerns the gene KMO and juvenile Huntington disease.